Respiratory Complex II and SCOT-Oxct1 Compete for succinyl-CoA in Ketolytic Dependent Tumours

Authors

  • Maurice Israël Institut Alfred Fessard CNRS 2 Av., Terrasse 91190 Gif-sur-Yvette, France
  • Eric Berg 4501 Ford Ave., Alexandria, VA 22302, USA
  • Guy Tenenbaum 5558 E Leitner Drive Coral Springs, FL 33067, USA

DOI:

https://doi.org/10.14738/bjhmr.111.16217

Keywords:

Tumour cell metabolism, SCOT- Oxct1, Ketolysis, Respiratory complexes

Abstract

The present work recalls main features of tumour cell metabolism, explaining their ketolytic dependency and vulnerability; we explored the interface between the respiration chain complexes and the nutritional supply of succinyl-CoA to the ketolytic enzyme SCOT- Oxct1. We indicated several target points in ketolysis and fatty acid synthesis pathways that would affect tumour cells, rendered vulnerable by their ketolytic dependency.

References

Warburg, O., On the respiratory impairment in cancer cells. Science, 1956. 124: p 269-370.

Mazurek, S., E. Eigenbrodt, The tumor metabolome. Anticancer Res., 2003, 23: p 1149-1154.

Hitosugi, T., et al., Tyrosine phosphorylation of mitochondrial Pyruvate dehydrogenase kinase 1Is important for cancer metabolism, Molecular Cell, 2011. 44: p 864-877.

Abolhassani, R., et al., Inhibition of SCOT and ketolysis decreases tumor growth and inflammation in the Lewis Cancer model. Japanese Journal of Oncology and clinical Res., 2022, 3: p 201-213.

Israel, M., E. Berg, and G. Tenenbaum, Cancer Metabolism: Fasting reset, The Keto-Paradox and drugs for undoing. Journal of Clinical Medicine, 2023. 12: p 1589-1602.

Israel, M., L. Schwartz, Inhibition of the ketolytic acetyl CoA supply to tumors could be their” Achilles’ heel”. Int. J. Cancer, 2020, 147: p1755-1757.

Israel, M., L. Schwartz, SCOT is a vital enzyme for tumors: With reference to Carney Triad Cancers and the ketogenic diet. Trends in Res., 2020, 3: p 1-2.

Schiller, J., V. Zickermann, Binding of natural inhibitors to Respiratory Complex I. Pharmaceuticals, 2022, 15: p 1088-1100.

Xue, W., S., Men, and R. Liu. Rotenone restrains the proliferation, motility and epithelial- mesenchymal transition of colon cancer cells and the tumourigenesis in nude mice via PI3K: Akt pathway. Clin. Exp. Pharmacol.Physiol.,2020, 47(8): p 1484-1494.

Harada, Y., et al., 5- Aminolevulinic acid- induced protoporphyrin IX fluorescence imaging for tumor detection: recent advances and challenges. Int. Mol. Sci., 2022, 23 (12): p 6478-6501.

Lee, M.D., et al., Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics. J. Clin. Invest., 2004, 114(8): p 1107- 1123.

Bakir, B., et al., Effects of thymoquinone supplementation on somatostatin secretion in pancreas tissue of rats. Kafkas Univ Vet Fak Derg, 2017, 23 (3): p 409-413,

Benjamin, D., et al., Dual inhibition of Lactate transporters MCT1 and MCT4 is synthetic lethal with metformin, due to NAD+ Depletion in cancer cells. Cell Rep., 2018, 25: p 3047-3058.

Konishi, Y., S. Kobayashi, and M. Shimizu. Tea polyphenols inhibit the transport of dietary phenolicacid transporter (MCT) in intestinal Caco -2 cell monolayers. J.Agric. Food Chem., 2003, 51: p 7296-7302. 100

Ayat, M., Dichloroacetate is promising for treating haematological malignancy through inhibiting ketone bodies oxidation. Towards better understanding of its anticancer mechanism. American Journal of Cancer Prevention, 2018, 6: p 5-8.

Albatany, M., S. Meakin, and R. Bartha. The monocarboxylate transporter inhibitor Quercetin induces internal acidification in a mouse model of glioblastoma multiforme: invivo detection using magnetic resonance imaging. Invest. New Drugs, 2019, 37(4): p 595-601.

Lee, K. H., et al. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis. Mol. Med.Reports, 2017, 15(4): p 2163-2173.

Liu Q., et al. Rhein, an inhibitor of adipocyte differentiation and adipogenesis. Journal of Asian Natural products. 2011, 13 (8): p714-723.

Pickart, C.M., W.P. Jencks. Formation of stable anhydrides from CoA transferase and hydroxamic acids. J. Biol. Chem., 1979, 254: p 9120-9129. 9120–9129.

Kosu, T., et al., Effect of orally administered bovine lactoferrin on growth of adenomatous Colorectal polyps in a randomized, placebo –controlled clinical trial. Cancer Prev Res., 2009 2 (11): p 975-983.

Israel, M. Signaling and metabolism in cancer: endocrine pancreas deficiency and hybrid anabolismcatabolism, drugs that undo the process. Cancer Therapy, 2014, 10: p1-12.

Al Batran, R., et al. Pimozide Alleviates Hyperglycemia in Diet–induced obesity by inhibiting Skeletal muscle Ketone oxidation. Clinical and Translational Report, 2020, 31(5): p909-919.

Focke, M., A. Feld, and K. Lichtenthaler. Allicin a naturally occurring antibiotic from garlic Specifically inhibits acetyl-CoA synthetase. FEBS. 1990, 261: p 106-108.

Bernstein, B.A., T. Richardson, and C.H. Amundsen. Inhibition of Cholesterol biosynthesis and Acetyl- CoA synthetase by Bovine Milk and Orotic acid. J. Dairy Sci.,1977, 60: p 1846- 1853.

Nguyen, P.H., et al., New dammarane-type glucosides as potential activators of AMP-activated Protein kinase (AMPK) from Gymnostemma pentaphyllum. Bioorganic and Medicinal Chemistry. 2011, 19: p 6254-6260.

Yoshino, M., E. Miyajima, and K. Tsushima. Kinetics of the interactions of AMPdeaminase with Fatty acids. J. Biol. Chem., 1979, 254: p1521-1525.

Ouyang, J., R.A. Parakhia, and R.S. Ochs. Metformin activates AMP kinase through inhibition of AMPdeaminase. Journal of Biological Chemistry, 2011, 286(1): p 1-11.

Min, K-J. et al. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAP phosphorylation. Food and Chemical toxicology, 2013, 58: p 77-85.

Yang, C-H. et.al. Multi-Targeting Andrographolite, a Novel NF-kB inhibitor, as a potential therapeutic agent for Stroke. Int.J.Mol.Sci.,2017, 18: p1683-1697.

Elyaguov, J. et al. Potentiation of anticancer effect by combination of mushroom extract and grape seed extract on human bladder cancer cells. Cancer Sci. Res., 2021, 4(2): 1-7.

Downloads

Published

2024-01-11

How to Cite

Israël, M., Berg, E., & Tenenbaum, G. (2024). Respiratory Complex II and SCOT-Oxct1 Compete for succinyl-CoA in Ketolytic Dependent Tumours. British Journal of Healthcare and Medical Research, 11(1), 93–101. https://doi.org/10.14738/bjhmr.111.16217